| No headlines available for LOGSX. |
| | | Morningstar Overall Rating: |  | | Total Assets: | 17.93M | | Category: | Health | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 31.07% | | 5y Avg Return: | 4.10% | | Rank in Category (ytd): | 6 | | % Rank in Category (ytd): | 3.64% | | Beta (3y): | 0.76 | | Morningstar Risk Rating: | Average |
|
| The investment seeks long-term capital appreciation. The fund normally invests at least 80% of net assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. These types of companies generally include pharmaceutical firms, designers and manufacturers of medical equipment and supplies, operators of hospitals, and biotechnological researchers. It invests in small- and mid-cap companies. The fund is nondiversified. | | | Fund Profile |
|
Help
0.09 (0.76%) 
Summary
Add LOGSX to Portfolio 
Download Data
